Ginko bioworks stock.

Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA). Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, ... The all-stock deal values Zymergen at $300 million market capitalization, ...Ginkgo Bioworks reported Q2 revenue of $81 million, down 44% YoY, mainly due to a decline in Biosecurity revenue. Read more about DNA stock here.View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Discover historical prices for DNA stock on Yahoo Finance. View daily, weekly or monthly format back to when Ginkgo Bioworks Holdings, Inc. stock was issued. 1 thg 3, 2023 ... Ginkgo Bioworks Q4 2022 Update & Business Review ... 3 Must Buying Renewable Energy Stocks In India For Long-Term | Green Energy Stocks | Harsh ...

Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...You can buy and sell Ginkgo Bioworks (DNA) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.

Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA).Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...Ginkgo Bioworks originally told investors to expect full-year 2022 revenue of at least $160 million from the biosecurity unit. ... Want TheStreet’s best daily stock and investing news right in ...With Ginkgo Bioworks Holdings stock trading at $1.46 per share, the total value of Ginkgo Bioworks Holdings stock (market capitalization) is $3.09B. Ginkgo Bioworks Holdings stock was originally listed at a price of $10.88 in Feb 24, 2021. If you had invested in Ginkgo Bioworks Holdings stock at $10.88, your return over the last 2 …

In addition, Ginkgo Bioworks Holdings, Inc. has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal ...

There was plenty of action in Ginkgo Bioworks ( DNA -2.06%) stock on Thursday, but not the kind the company probably like. Investors sold out of the biotech following the publication of its latest ...

Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Which Ginkgo Bioworks insiders have been buying company stock? The following insider purchased DNA shares in the last 24 months: Shyam Sankar ($512,000.00). How much insider buying is happening at Ginkgo Bioworks?With its shares popping by more than 21% in a day in the aftermath of its latest earnings report, Ginkgo Bioworks ( DNA 4.11%) is a hot biotech company that's ripe for investment. After reporting ...Ginkgo Bioworks Stock Forecast - Analyst Ratings. Eight FactSet analysts have an Overweight consensus rating on DNA stock with a share price target of $5.29, which is below the August consensus of $7.98. Analyst Matt Larew of William Blair reiterated his Buy rating on DNA stock, as did Stephen Mah of Cowen & Company, with a $12 …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...

Feb 17, 2023 · Last year was not a good one for Ginkgo Bioworks’ stock price, which dropped 80%. Ginkgo’s business model is that it wants to be the Apple (NASDAQ:AAPL) App Store of biotech, the one-stop-shop ... Ginkgo Bioworks reported Q2 revenue of $81 million, down 44% YoY, mainly due to a decline in Biosecurity revenue. Read more about DNA stock here.Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ...Ginkgo Bioworks (DNA-7.19%) is a biotech that's operating on multiple bleeding edges of innovation as it works to engineer and manufacture biological cells at scale. Between its highly automated ...Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ... Ginkgo Bioworks went public two years ago via a special purpose acquisition company. Deep losses and significant cash burn have made investors wary of investing in this risky stock. Special ...

With its shares popping by more than 21% in a day in the aftermath of its latest earnings report, Ginkgo Bioworks ( DNA 4.11%) is a hot biotech company that's ripe for investment. After reporting ...

As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...Evgenii Kovalev. Ginkgo Bioworks (NYSE:DNA) is still finding its feet as a public company, with the stock continuing to decline on the back of valuation concerns and declining Biosecurity revenue ...Second Quarter 2023 Financial Highlights. Second quarter 2023 Total revenue of $81 million, down from $145 million in the comparable prior year period, a decrease of 44% primarily driven by the ...Phone Number +1 877 422 5362. Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial ...7 thg 2, 2022 ... Ginkgo's Platform: A Foundry Tour (Ginkgo Bioworks Investor Day 2021) ... Why We're Avoiding Ginkgo Bioworks Stock $DNA. Nanalyze•12K views · 58 ...Shares of Ginkgo Bioworks ( NYSE: DNA) have sharply corrected in Q1 2022 and Q4 2021. Rate hikes and inflationary pressures have recently compressed multiples for companies with distant free cash ...Ginkgo Bioworks (NYSE:DNA) ... Ginkgo is acquiring Zymergen in an all-stock transaction that values Zymergen at approximately a 300 million USD market capitalization. The stated aim of the ...

Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.

With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

By Chris MacDonald, InvestorPlace Contributor Nov 18, 2022, 1:55 pm EST. Ginkgo Bioworks ( DNA) stock has fallen out of favor in the market. However, Cathie Wood appears to remain very bullish on ...See the latest DNA Stock price for Ginkgo Bioworks Holdings Inc and NYSE: DNA stock rating, related news, valuation, dividends and more to help you make your investing decisions.Evgenii Kovalev. Ginkgo Bioworks (NYSE:DNA) is still finding its feet as a public company, with the stock continuing to decline on the back of valuation concerns and declining Biosecurity revenue ...1. Ginkgo Bioworks. Ginkgo Bioworks is a biotech company that went public through a special purpose acquisition company last year. The company has the backing of Bill Gates and can design and ...Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis. The honeymoon for newly minted Ginkgo Bioworks ( DNA 4.11%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ...Why Ginkgo Bioworks Stock Was Plummeting on Thursday msn.com - November 9 at 6:24 PM: Foremost Farms Selects Ginkgo Bioworks to Develop Technology for Upcycling Dairy Co-products finance.yahoo.com - November 9 at 8:24 AM: Cathie Wood sinks nearly $2 million into falling tech stock msn.com - November 8 at …Oct 6, 2022 · Wood keeps buying DNA stock despite it being down more than 60% so far this year. Cathie Wood has been adding shares of biotech company Ginkgo Bioworks ( DNA) to her exchange-traded funds (ETFs ... Scorpion Capital's cutting presentation of Ginkgo Bioworks is lengthy. In over 170 slides, Scorpion walks investors through an exhaustive review of the company, pleading the case that the company ...Nov 8, 2023 · Third quarter 2023 Total revenue of $55 million, down from $66 million in the comparable prior year period, a decrease of 17% primarily driven by the expected ramp down of K-12 testing in Ginkgo's ... Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock ...

8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.See Ginkgo Bioworks Holdings, Inc. (DNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Aug 18, 2021 · While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. Nov 24, 2023 · Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion. Instagram:https://instagram. how much is the buffalo nickel worth1921 morgan silver dollar worthstate farm jewelry insurancecfd brokers for us citizens Right now, of course, Ginkgo is unprofitable, and the stock market has no appetite for risky high-growth names. So while there was a lot of excitement when Ginkgo shares hit the market, the stock ...Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ... budstock2009 lincoln bicentennial penny Ark Invest has purchased more than 3.5 million shares of Ginkgo Bioworks since June 29.; The biotech company is now the fund’s 23rd largest holding. Shares of DNA stock are down over 65% year-to ...DNA Stock Down on Scorpion Capital Short Report. Activist short-seller Scorpion Capital announced its short position today on Ginko Bioworks. Via a detailed short report, the company outlines ... sava stock news About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food ...The latest Ginkgo Bioworks Holdings stock prices, stock quotes, news, and DNA history to help you invest and trade smarter. Menu icon A vertical stack of three evenly spaced horizontal lines.